Results 191 to 200 of about 178,661 (314)

Regulation of mucus secretion by cells isolated from the rat gastric mucosa.

, 1990
Andrew C. Keates, Peter J. Hanson
openalex   +2 more sources

GLP‐1 agonists and the gut microbiome: A bidirectional relationship

British Journal of Clinical Pharmacology, EarlyView.
Abstract Glucagon‐like peptide‐1 (GLP‐1) receptor agonists have transformed the management of type 2 diabetes mellitus (T2DM) and obesity, yet their interactions with the gut microbiome remain an emerging frontier in pharmacological and metabolic research.
Srinivas Kamath, Nicole S. L. Chan, Paul Joyce   +2 more
wiley   +1 more source

Schizophyllum commune-associated allergic bronchopulmonary mycosis in a postoperative lung cancer patient: A case report and comprehensive literature review. [PDF]

Medicine (Baltimore)
Wu N, Liang Y, Yan Q.
europepmc   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

British Journal of Clinical Pharmacology, EarlyView.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse, Christophe Hommel, Nadine Petitpain, Philippe Kerschen   +3 more
wiley   +1 more source

Immune activation and mucin dysregulation in pediatric refractory <i>Mycoplasma pneumoniae</i> pneumonia with mucus plugs. [PDF]

Front Cell Infect Microbiol
Liu F, Wang Q, Cheng Q, Zhang H.
europepmc   +1 more source

Nanostructured drug delivery systems for posterior segment eye diseases: Strategies to defy ocular barriers

BMEMat, EarlyView.
Efficient drug delivery to the posterior segment of the eye has long been a challenging issue due to the complex ocular barriers. The review focuses on the promise held by nanoplatforms for barrier penetration and the key mechanisms involved, also highlighting their advantages in achieving efficient drug delivery and superior treatment of PSEDs ...
Yifan Shen, Ying Yao, Yan Zhang, Xinyu Shi, Ling Bai, Yang Zhong, Yan Zhang, Kun Zhang   +7 more
wiley   +1 more source

In Vitro Evaluation of the Effect of Size and PEGylation on Inhalable Liposomes for Pulmonary Drug Delivery. [PDF]

Nanomaterials (Basel)
Carrillo-Romero J, Fernández-Méndez L, de la Iglesia E, Katsumiti A, Germán L, Silvio DD, Ruíz-Cabello J, Carregal-Romero S, Goñi-de-Cerio F.   +8 more
europepmc   +1 more source

Quantitative adverse outcome pathway modeling for cigarette smoke-inducible airway mucus hypersecretion. Part 2: Bayesian network modeling for probabilistic risk estimation [PDF]

Shigeaki Ito, Sakuya Ichikawa, Risa Matsumoto, Shugo Muratani, Keigo Sano, A. Mori, Kazuo Erami   +6 more
openalex   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Proteomic signatures of cervical mucus associated with fertility in Bali heifers (<i>Bos javanicus</i>): Implications for biomarker-based selection in artificial insemination programs. [PDF]

Vet World
Yusuf M, Toleng AL, Hasrin H, Baharun A, Diansyah AM, Santoso S, Rahmat R, Alfian AM, Masturi M, Sahiruddin S, Amrullah MF, Adam AAS, Jannah M.   +12 more
europepmc   +1 more source